Cover Page The handle
Hele tekst
(2) Chapter 1 GENER AL INTRODUC TION AND OUTLINE OF THE THESIS.
(3) Chapter 1. GENERAL INTRODUCTION AND OUTLINE OF THE THESIS Introduction. ÀV`iÞ`Ãi>Ãi
(4) ®Ã>ÜÀ`Ü`i}ÀÜ}i«`iV>ÃÃV>Ìi`ÜÌ an increased risk of cardiovascular morbidity and mortality.1-4 Heart failure is particularly frequent among patients with CKD.2 Pressure and volume overload >` i`Þ>Vv>VÌÀÃ>ÃÃV>Ìi`ÜÌ
(5) `ÕViivÌÛiÌÀVÕ>À6® Þ«iÀÌÀ« Þ]Ài`ÕViV>«>ÀÞ`iÃÌÞ>`VÀi>ÃiÞV>À`>wLÀÃÃÌ >Ìi>` Ì6`>ÃÌV>`ÃÞÃÌV`ÞÃvÕVÌ°5 These processes have been proposed as important determinants of increased mortality in this population.5 The most frequent cause of death in patients with advanced CKD is sudden cardiac death; there is an enhanced arrhythmogenicity due to an increased «ÀiÛ>iVivV>À`>VÀÃv>VÌÀÃÃÕV >ÃVÀ>ÀÞ>ÀÌiÀÞ`Ãi>Ãi]6 Þ«iÀÌÀ« Þ >`ÞV>À`>wLÀÃÃ]>ÃÜi>ÃV>À`>V
(6) ëiVwV®ÀÃv>VÌÀÃÃÕV as electrolyte alterations, sympathetic hyperactivity, uremia and anemia. 2,6 Patients with CKD also have an increased risk for developing valvular heart disease due to hemodynamic factors and metabolic pathways that promote Û>ÛÕ>À V>VwV>Ì] V>À`>V `>Ì>Ì >` viVÌÛi i`V>À`Ìð7,8 Finally, >ÌÀ>wLÀ>Ìë>ÀÌVÕ>ÀÞvÀiµÕiÌ«>ÌiÌÃÜÌ >`Û>Vi`
(7) `ÕiÌ electrical and structural remodeling of the atrial myocardium as a consequence of hemodynamic and metabolic disturbances.9-13 Left ventricular systolic dysfunction in patients with chronic kidney disease 6iiVÌvÀ>VÌ6 ®]V>VÕ>Ìi`vÀÌÜ`iÃ>iV V>À`}À>« Þ] ÃÌ iÃÌvÀiµÕiÌÞÕÃi`«>À>iÌiÀÌ`iwi6ÃÞÃÌV`ÞîvÕVÌ14, and is strongly associated with HF and increased mortality in patients with CKD.15,16 ÜiÛiÀ]6 >ÃLiià ÜÀ>Ì iÀÃiÃÌÛiÌÌ i`iÌiVÌv6ÃÞÃÌV `ÞÃvÕVÌ]«>ÀÌVÕ>ÀÞ«>ÌiÌÃÜÌ
(8) °Ì iÃi«>ÌiÌÃ]6 Þ«iÀÌÀ« Þ >` V >}iÃ Ì i 6 ÃÌÀÕVÌÕÀi >Þ i>` Ì ÃÕLÌi 6 ÃÞÃÌV `ÞÃvÕVÌ `iëÌi«ÀiÃiÀÛi`6 °17 In the last years, several advances in echocardiography ÀiÃÕÌi`Ûi`ViÃÀ`iÀÌ«ÀÛiV >À>VÌiÀâ>Ìv6vÕVÌ°/Ü dimensional speckle tracking echocardiography provides more insight in cardiac iV >VÃ>`6«iÀvÀ>Vi°6}L>}ÌÕ`>ÃÌÀ>-®]>ÃÃiÃÃi`ÜÌ two-dimensional speckle tracking echocardiography, may provide more detailed vÀ>Ì6ÃÞÃÌVvÕVÌ°18 9iÌ]`>Ì>Ì i«ÀiÛ>iVivÃÕLÌi6 ÃÞÃÌV`ÞÃvÕVÌ]>VVÀ`}Ì6-«>ÌiÌÃÜÌ
(9) >`«ÀiÃiÀÛi`. 10.
(10) General Introduction. 6 >ÛiÌLiiiÝ«Ài`Ì`>Ìi°/ iVÀiiÌ>«À}ÃÌVÛ>Õiv6 -ÛiÀ6 >ÃLii`iÃÌÀ>Ìi`«>ÌiÌÃÜÌ Û>ÀÕÃV>À`Û>ÃVÕ>À `Ãi>Ãià ÃV iV i>ÀÌ `Ãi>Ãi] Û>ÛÕ>À i>ÀÌ `Ãi>Ãi >` i>ÀÌ v>ÕÀi®°19 ÜiÛiÀ]ÌÌiÃÜ>LÕÌÌ i>ÃÃV>ÌLiÌÜii6->`ÃÕÀÛÛ> patients with CKD.19 6 iV >V> `ëiÀà Ài«ÀiÃiÌà 6 iV >V> `ÞÃÃÞV ÀÞ >` à i>ÃÕÀi`ÜÌ ÌÜ`iÃ>ëiViÌÀ>V}iV V>À`}À>« Þ°6->` 6iV >V>`ëiÀÃ>Ài«ÌiÌ>ÀÃ>ÀiÀÃvÛiÌÀVÕ>À>ÀÀ ÞÌ >à «>ÌiÌÃÜÌ
(11) °*>ÌiÌÃÜÌ >`Û>Vi`
(12) >ÞLiiwÌvÀ>«>Ì>Li V>À`ÛiÀÌiÀ`iwLÀ>ÌÀ
(13) ®vÀ«ÀiÛiÌvÃÕ``iV>À`>V`i>Ì °ÜiÛiÀ] they also show an increased risk of ICD-related complications.20-22 Therefore, Ì iÀi à > ÕiÌ ii` vÀ >VVÕÀ>Ìi Àà ÃÌÀ>ÌwV>Ì ÌÃ Ì `iÌvÞ
(14) patients at risk of ventricular arrhythmias and sudden cardiac death. Valvular heart disease in patients with chronic kidney disease Patients with CKD have an increased risk for developing valvular heart disease, however they are often denied or not referred to surgery due to the increased operative risk.23,24/ i«À}ÃÌV«V>ÌÃvÕÌÀi>Ìi`ÃiÛiÀi6
(15) Ì i }iiÀ>««Õ>Ì>ÀiÜiÜ]LÕÌ >ÛiÌLiiÃÌÕ`i`iÝÌiÃÛiÞ patients with CKD.25 Underscoring the need of additional studies regarding the prevalence of valvular heart disease in patients with CKD and the frequency of referral for surgical or transcatheter valve intervention. In CKD patients, valvular calcium is an important underlying mechanism vÛ>Ûi`ÞÃvÕVÌ°6>ÛÕ>ÀV>VÕÃ>ÃÃV>Ìi`ÜÌ >VÀi>Ãi`ÀÃv all-cause mortality in patients with end-stage renal disease.26,27 However, the prognostic implications of left-sided valve calcium in patients with stage 2 and Î
(16) i,vÈänÉÉ£°ÇÎÔ>`ÎäxÉÉ£°ÇÎÔÀiëiVÌÛiÞ® are unknown. #VTKCNƂDTKNNCVKQPKPRCVKGPVUYKVJEJTQPKEMKFPG[FKUGCUG ƂÌÀ>wLÀ>ÌÃÛiÀÞVi`ÃÌ>}iÀi>`Ãi>Ãi«>ÌiÌÃ>`Ì i V`iViviÜÞ`>}Ãi`>ÌÀ>wLÀ>Ì`iÀ«>ÌiÌÃÌ>Ì}`>ÞÃà is 5-fold higher than in the general population.9-11 Electrical and structural Ài`i}vÌ i>ÌÀ>ÞV>À`ÕÃiÀÛiÃ>Ã>ÃÕLÃÌÀ>ÌivÀ>ÌÀ>wLÀ>Ì°12 In patients with end-stage renal disease, the metabolic and hemodynamic `ÃÌÕÀL>ViÃ>ÃÃV>Ìi`ÜÌ `>ÞÃÃ>Þ`Õ>ÌiÌ i>ÌÀ>wLÀ>ÌÃÕLÃÌÀ>Ìi. 11.
(17) Chapter 1. VÌÀLÕÌ}ÌÌ i } V`iViv>ÌÀ>wLÀ>Ì°13 To date, the structural Ài`i}vÌ iivÌ>ÌÀÕ >ÃÌLiiV >À>VÌiÀâi`Ì Ã}ÀÕ«v«>ÌiÌð Outline of the thesis The aim of this thesis was to evaluate cardiac mechanics using two-dimensional ëiVi ÌÀ>V}® iV V>À`}À>« Þ >` VÀ>ÀÞ V«ÕÌi` Ì}À>« Þ >}}À>« Þ «>ÌiÌà ÜÌ
(18) Ì `iwi Ì i «ÀiÛ>iVi >` «À}ÃÌV implications of cardiovascular diseases. In Part 1 the value of two-dimensional speckle tracking echocardiography was ÛiÃÌ}>Ìi`vÀ>ÃÃiÃÃ}6->`6iV >V>`ëiÀë>ÌiÌÃÜÌ CKD and its prognostic implications. Chapter 2 >>ÞÃiÃ6-]>ÃÃiÃÃi`LÞ two-dimensional speckle tracking echocardiography, in pre-dialysis and dialysis «>ÌiÌÃÜÌ «ÀiÃiÀÛi`6 °Chapter 3 evaluates the prognostic implications v6-«Ài`>ÞÃÃ>``>ÞÃë>ÌiÌðChapter 4 discusses the value of 6iV >V>`ëiÀÃ>`6->ÃÀÃ>ÀiÀÃvÛiÌÀVÕ>À>ÀÀ ÞÌ >à in pre-dialysis and dialysis patients. Part II focuses on the prevalence and prognostic implications of valvular heart disease and mitral and aortic valve calcium in patients with CKD. Chapter 5 investigates the prevalence and prognostic value of valvular heart disease in pre-dialysis and dialysis patients. Chapter 6 describes the prevalence and prognostic implications of mitral and aortic valve calcium in patients with CKD. Part III vVÕÃiÃ>ÌÀ>wLÀ>Ì«>ÌiÌÃÜÌ i`ÃÌ>}iÀi>`Ãi>Ãi° Chapter 7 provides more insight on the echocardiographic associates of atrial wLÀ>Ì«>ÌiÌÃÜÌ i`ÃÌ>}iÀi>`Ãi>Ãi°. 12.
(19) General Introduction. REFERENCES £° Ƃ-] iÀÌÜ]>
(20) ]V ÕV CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular iÛiÌÃ]>` ëÌ>â>Ì°N Engl J Med 2004;351:1296-1305. 2. United States Renal Data System. 2016 USRDS annual data repor t: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2016. ΰ 7i *] i}/9]/Ã>] >}9 ] Chan HT, Tsai SP, Chiang PH, Hsu CC, -Õ}*]ÃÕ9]7i-°ƂV>ÕÃi mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008;371:2173-2182. {° >`L> -] À}>Ì ] iÀÀ *]
(21) ÕÃÌ>
(22) 7]7iLÀ/Ƃ]<iÌ*<] Atkins RC. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol 2003;14:S131138. x° iÀâ} Ƃ]ƂÃ}iÀ,7] iÀ}iÀƂ]. >ÀÞÌ>
(23) ]
(24) iâ]>ÀÌ,] V>À`Ì KU, Kasiske BL, McCullough PA, *>ÃÃ>,-]
(25) i>V --]*Õ*],Ìâ ° Cardiovascular disease in chronic kidney disease. A clinical update from Kidney
(26) Ãi>Ãi\«ÀÛ}L>"ÕÌViÃ
(27) "®°Kidney Int 2011;80:572-586. È° À>]->ÛiiÛ>]
(28) >Ƃ]
(29) i >À ]iÀÀ ]ÃÀ>i 7]>i
(30) Ƃ]> >>]ÀÌ]Ì>ÃƂ]6Ã Ƃ] /ÕÀ> > *] « 9° ÀV kidney disease in patients with cardiac. rhythm disturbances or implantable iiVÌÀV>`iÛViÃ\VV>Ã}wV>Vi and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia *>VwVi>ÀÌ, ÞÌ -ViÌÞ°Europace 2015;17:1169-1196. Ç° `]*>iÀ ]>ÀV >Ã-] ÕiÀƂ*° >VwV>ÌvÌ i>ÀÌV Û>ÛiÌ i`>Þâi`«>ÌiÌ°J Am Soc Nephrol 2000;11:778-783. n°
(31) ] - 9] } ,] ]. >}]>7] Õ} ° vviVÌv End-Stage Renal Disease on Rate of Progression of Aortic Stenosis. Am J Cardiol 2016;117:1972-1977. 9. Zimmerman D, Sood MM, Rigatto C, Holden RM, Hiremath S, Clase CM. Systematic review and meta-analysis of incidence, prevalence and outcomes of >ÌÀ>wLÀ>Ì«>ÌiÌÃ`>ÞÃð Nephrol Dial Transplant 2012;27:38163822. £ä°`ÃÌi Ƃ]ƂÀVi ]>ÌÞƂ] /ÕÀ> >]-iÌ}ÕV -]7i>ÞiÀ 7 °/Ài`ÃÌ iV`iViv>ÌÀ> wLÀ>Ì`iÀ«>ÌiÌÃÌ>Ì} dialysis in the United States. Circulation 2012;126:2293-2301. 11.*VV *] > ] -iÀ ] iÃi* ]iÀ>`iâƂ]iVLiÀÌ -,] i> ] ÕÀÌðV`iVi >`«ÀiÛ>iViv>ÌÀ>wLÀ>Ì>` associated mortality among Medicare LiiwV>ÀiÃ]£ÎÓääÇ°Circ Cardiovasc Qual Outcomes 2012;5:85-93. £Ó°ƂiÃÃi ] ƂÕÃ> ] -V ÌÌi 1° Electrical, contractile and structural Ài`i}`ÕÀ}>ÌÀ>wLÀ>Ì°. 13.
(32) Chapter 1 Cardiovasc Res 2002;54:230-246. £Î°À>Ìâ«ÕÃ*]ÀÃ-]Õ/] *ÀÌ«Ã>ÌÃ]]Õ`iÛiÃƂ° ƂÌÀ> wLÀ>Ì i`ÃÌ>}i Ài> disease. Pacing Clin Electrophysiol 2007;30:1391-1397. £{°>},] >`>*]ÀƂÛ6]Ƃw> ]ƂÀÃÌÀ}Ƃ] À>`i]>V Ã>«v Ƃ]ÃÌiÀ ]`ÃÌi-Ƃ]ÕâiÌÃÛ> T, Lancellotti P, Muraru D, Picard MH, ,iÌâÃV i ,],Õ`Ã]-«iViÀ/] /Ã>}7]6}Ì1°,iVi`>Ìà for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16:233-270. £x°*>Þi]- >À>-]
(33) ii
(34) ]Õ] Alemu F, Balogun RA, Malakauskas SM, Kalantar-Zadeh K, Kovesdy CP. Association of echocardiographic abnormalities with mortality in men with non-dialysis-dependent chronic kidney disease. Nephrol Dial Transplant 2012;27:694-700. £È°*>ÀvÀiÞ*-]iÞ, ]>ÀiÌÌ
(35) ]iÌ ]ÕÀÀ>Þ
(36) ] >ÀÀi* °"ÕÌVi and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996;11:1277-1285. 17. Unger ED, Dubin RF, Deo R, Daruwalla 6]Ài`>]i`> ] iÕÃÃ ]Àii` ]- > -°ƂÃÃV>Ìv chronic kidney disease with abnormal cardiac mechanic s and adverse outcomes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 2016;18:103-112. £n°/«Ã]
(37) i}>`6]>ÀÃ> Ƃ] >Ý. 14. °ÞV>À`>ÃÌÀ>Ì`iÌiVÌÃÕLÌi left ventricular systolic dysfunction. Eur J Heart Fail 2017;19:307-313. £°>> ] "Ì> > *] >À ÜV /° *À}ÃÌV«V>ÌÃv}L>6 dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart 2014;100:1673-1680. Óä°ÀiÞLi ] ââi``i ,] i` ] >ÀÀ}Ì7] >â>â,]>â]> -] }ÜÕ"]` ]->L>-°,i> ÃÕvwViVÞ«Ài`VÌÃÌ iÌiÌwÀÃÌ >««À«À>Ìi `iwLÀ>ÌÀ Ã V° Am Heart J 2006;151:852-856. 21. Makki N, Swaminathan PD, Hanmer ] "Ã >ÃÞ °
(38) «>Ì>Li cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies. Europace 2014;16:55-62. ÓÓ° ÕÌi -]
(39) i i ] 6>
(40) iÀ i`iƂ ],Ì>Ã] ÌÃ>] >ÀVÀiiÛi`]7ÌiÀLii,] ,>Li/]Õi>7]-V >]6> Erven L. Chronic kidney disease and «>Ì>LiV>À`ÛiÀÌiÀ`iwLÀ>ÌÀ related complications: 16 years of iÝ«iÀiVi°J Cardiovasc Electrophysiol 2014;25:998-1004. ÓΰÕ} ] >À] ÕÌV >ÀÌ ]
(41) i> >Þi ] i >ÀÜv ] iÛ>} "7] /ÀÃ*]6>ÛiÀÃV i`i]6iÀiiÀ ] iÀÃ> ],>Û>Õ`*]6> >>Ƃ° A prospective survey of patients with valvular heart disease in Europe: The ÕÀi>ÀÌ-ÕÀÛiÞ6>ÛÕ>Ài>ÀÌ Disease. Eur Heart J 2003;24:1231-1243. Ó{°iÀâ} Ƃ]><] ÃƂ°}ÌiÀ survival of dialysis patients in the United.
(42) General Introduction States with prosthetic heart valves: à Õ`Ƃ. ÉƂƂ«À>VÌVi}Õ`iià Û>ÛiÃiiVÌLi`wi`¶Circulation 2002;105:1336-1341. Óx° à ÕÀ>,Ƃ]"ÌÌ ] Ü,"]. >À>Li Ƃ] ÀÜ*]ÎÀ`]ÕÞÌ,Ƃ] "½>À>*/],Õâ ]-ÕL>à ]-À>>*] -Õ`Ì/]ÎÀ`]/ >Ã
(43) °Óä£{ƂƂÉ ACC guideline for the management of patients with valvular heart disease: a report of the American College of. >À`}ÞÉƂiÀV>i>ÀÌƂÃÃV>Ì />ÃÀVi*À>VÌViÕ`iiðJ Am Coll Cardiol 2014;63:e57-185. ÓÈ°,>}}*] i>ÃƂ]>L> ]iÀÀ>ÃV> ],>ÌÌ ] VƂ]ÕÌiÀ*°Ƃ cause mortality in hemodialysis patients ÜÌ i>ÀÌÛ>ÛiV>VwV>Ì°Clin J Am Soc Nephrol 2011;6:1990-1995. 27. Takahashi H, Ishii H, Aoyama T, Kamoi D, Kasuga H, Ito Y, Yasuda K, Tanaka M, Yoshikawa D, Maruyama S, Matsuo -]ÕÀ >À>/]9Õâ>Ü>9°ƂÃÃV>Ì vV>À`>VÛ>ÛÕ>ÀV>VwV>ÌÃ>` C-reactive protein with cardiovascular mortality in incident hemodialysis «>ÌiÌÃ\>>«>iÃiV ÀÌÃÌÕ`Þ°Am J Kidney Dis 2013;61:254-261.. 15.
(44)
(45)
GERELATEERDE DOCUMENTEN
The prevalence of ventricular conduction disorders increased in parallel with AS severity, which was particularly significant for left bundle branch block (4.3% in aortic
(1999) 40 Prospective Mean time since event 12 and 36 mo 145 To 191 pts, 142 caregivers HT patients that survived 6 weeks after surgery SCID interview (DSM-III-R ) on
Chapter 6 Prevalence and prognostic implications of mitral and aortic valve calcium in patients with chronic kidney
On all subscales of the MFI, patients reported more fatigue compared with norms of the general population, both before and 1 year after surgery.. In total, 68% and 57% of
Daar word egter self erken dat alhoewel daar die behoefte is om die gemeente se fokus alhoemeer te verskuif van onmiddelike verligting tot langtermyn ontwikkeling, dit nog ‘n
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of
Om de voer- opname te verbeteren wordt nu bij alle stations extra water tijdens het voeren vertrekt, Buiten het voerstation kan altijd onbeperkt water wor- den
The presence of mitral and/or aortic valve calcium was associated with poor survival in this population, but only mitral valve cal- cium was independently associated with increased